No. You'e been trading for 10 years, keep it real!
For most of the early years you were talking it down foot to the throat the entire time.
Over the recent past I've got whiplash from your shifts in sentiment.
Back in later then? I wouldn't mind but it's the half truths and bs that get me.
How about NOT making it all about you and just tell us why you imagine that MSB has not matured as a stock, despite this recent setback (of an opportunity that has arisen since Covid19, and hasn't taken off due to in no small part to the FDA obstacles).
Go on, you can talk about the stock and not yourself. Try it.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-353
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |